Lowy: Paylines to stay at FY21 levels

The FY22 spending bill increases NCI’s budget by $159 million—but according to NCI officials, this boost isn’t sufficient to raise paylines for R01 grants for established and new investigators.

NCI Director Ned Sharpless has been incrementally increasing funding for research project grants (RPGs) over the past several years, with the goal of getting paylines to the 15th percentile by 2025 (The Cancer Letter, Sept. 6, 2019; Sept. 4, 2020). Sharpless aimed to reach the 12th percentile in FY22 (The Cancer Letter, Dec. 10, 2021).

Recalibrating for the FY22 spending bill, NCI has decided that paylines for established and new investigators will remain at the 11th percentile, said Douglas Lowy, principal deputy director of NCI.

“We expect that 52% of the increase in the FY22 appropriation will be invested in the RPG pool,” Lowy said to the Board of Scientific Advisors March 28. “Despite the RPG prioritization, NCI has decided the FY22 R01 payline for experienced investigators will remain the same as in FY21.”

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

Byline

Alice Tracey

Reporter

DOWNLOAD THE PDF

Table of Contents

YOU MAY BE INTERESTED IN

Podcast

In the Headlines: What’s in Trump’s draft budget?

A confidential Trump administration budget document obtained by The Cancer Letter called for a 40% budget cut to NIH and a restructuring of the 27 existing NIH institutes and centers down to just eight. But what else is in it?

April 23, 2025

Vol.51 No.15

Podcast The Directors

The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty
“We are resolute. We are committed to continuing to move the work forward.”

Speaking on The Cancer Letter Podcast, Taofeek Kunle Owonikoko recalled recent conversations with two junior faculty members at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.

April 18, 2025

Vol.51 No.15

By Paul Goldberg

Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts

Confidential Trump administration budget documents show that the upcoming FY26 Budget Request will radically cut about $50 billion out of the U.S. Department of Health and Human Services, reshuffling agency components, and slashing the number of NIH institutes and centers to just eight.

NCI summarizes changes to the CCSG NOFO

In an email sent to directors and deputy directors of NCI-designated cancer centers, Krzysztof Ptak, director of the NCI Office of Cancer Centers, provided a comparison between the newly issued Cancer Center Support Grant Notice of Funding Opportunity with the previous version of the document.

April 18, 2025

Vol.51 No.15

Clinical Roundup

Inherited cancer mutations may drive tumor growth, study shows

Most cancer genome studies have focused on mutations in the tumor itself and how such gene variants allow a tumor to grow unchecked. A study led by researchers at Washington University School of Medicine in St. Louis takes a deep dive into inherited cancer mutations measured in a healthy blood sample and reports how those mutations might take a toll on the body’s cells starting at birth, perhaps predisposing a person to develop cancers at various stages of life.

April 18, 2025

Vol.51 No.15

Podcast

In The Headlines: Private funding can’t replace federal funding—but it can help

In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.

April 09, 2025

Vol.51 No.13

Lowy: Paylines to stay at FY21 levels

YOU MAY BE INTERESTED IN

In the Headlines: What’s in Trump’s draft budget?

The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty
“We are resolute. We are committed to continuing to move the work forward.”

Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts

NCI summarizes changes to the CCSG NOFO

Inherited cancer mutations may drive tumor growth, study shows

In The Headlines: Private funding can’t replace federal funding—but it can help

Renew today!

Subscriber content

Never miss an issue!

Login

Lowy: Paylines to stay at FY21 levels

YOU MAY BE INTERESTED IN

In the Headlines: What’s in Trump’s draft budget?

The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty“We are resolute. We are committed to continuing to move the work forward.”

Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eightNCI to remain intact, but its finances are uncertain; FDA is spared big cuts

NCI summarizes changes to the CCSG NOFO

Inherited cancer mutations may drive tumor growth, study shows

In The Headlines: Private funding can’t replace federal funding—but it can help

Never miss an issue!

Login

The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty
“We are resolute. We are committed to continuing to move the work forward.”

Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts